Cernilton is a prostate disease treatment agent based on plant pollen extract, developed by Japan's Dongling Pharmaceutical Industry Co., Ltd.

1、 Drug name

1. Product Name: Cernilton Tablets

2. Common name: Cernitin Pollen Extract

2、 Indications

1. Chronic prostatitis.

2. The following symptoms caused by early prostate enlargement: difficulty urinating, frequent urination, residual urine sensation and residual urine, painful urination, small urine stream, and discomfort in the perineum.

3、 Specifications and characteristics

1. Specification: Each tablet contains 63mg of active ingredient.

2. Appearance: This product is a light green vegetarian tablet.

4、 Main components

1. Active ingredient: Cernitin Pollen Extract 63mg/tablet.

2. This extract is made by mixing two components in a 20:1 ratio:

Shenitin T60:60mg/tablet (a powdered extract obtained by digesting plant pollen mixture with microorganisms and extracting it with water).

Shenitine GBX: 3mg/tablet (soft extract obtained by organic solvent extraction).

5、 Usage and dosage

1. Conventional dosage: usually 2 tablets per dose, taken orally 2-3 times a day.

2. Dose adjustment: It can be adjusted appropriately according to symptoms.

6、 Medication precautions

1. Usage: No specific requirements related to meals (before and after meals) were mentioned.

2. PTP packaging: This medication is packaged in PTP, and patients should be instructed to remove the medication from the PTP plate before taking it. If accidentally ingested, the sharp edges of the PTP plate may penetrate the esophageal mucosa and even cause perforation, leading to serious complications such as mediastinitis.

3. Moisture absorption: This medicine has strong moisture absorption, which can cause discoloration. After opening the aluminum-plastic packaging, attention should be paid to moisture-proof storage, and it should be removed from the PTP board before taking the medicine.

7、 Medication for special populations

There is currently no specific guidance on medication for special populations such as pregnant women, breastfeeding women, children, and the elderly. For more information, please consult a doctor.

8、 Adverse reactions

Other side effects: If abnormal conditions occur, medication should be stopped and appropriate measures taken. Adverse reactions with an incidence rate of 0.1% to 5% or an unknown frequency include:

1. Allergic reactions: rash, urticaria, etc.

2. Digestive system: nausea, loss of appetite, stomach discomfort, constipation, etc.

9、 Contraindications

According to general medication principles, individuals with a history of allergies to any ingredients of this product should be prohibited from using it.

10、 Storage method

1. Storage conditions: Store at room temperature.

2. Packaging sealing: Due to its strong hygroscopicity, aluminum-plastic packaging should be sealed and stored in a dry place after opening to avoid moisture.

3. Validity period: The validity period is 5 years.

Cerniltoninformation